ARROWHEAD PHARMACEUTICALS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $158k $31.4m $16.1m $168.8m $88.0m $138.3m $243.2m $240.7m $3.6m $829.4m
Operating Expenses $81.9m $68.4m $72.1m $107.6m $181.2m $287.3m $421.7m $445.7m $604.6m $731.1m
Operating Income (Loss) ($81.7m) ($37.0m) ($55.9m) $61.2m ($93.2m) ($149.0m) ($178.5m) ($205.0m) ($601.1m) $98.3m
Additional Financial Items
Amortization of Intangible Assets $1.7m $1.7m $1.7m $1.7m $1.7m $1.7m $1.7m $1.7m $1.7m $1.7m
Gain (Loss) on Investments ($4.4m) $0
Income (Loss) Attributable to Parent, before Tax $0 $0 $431k ($202.5m) ($612.5m) $51.5m
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($194.6m) ($582.3m) ($42.6m)
Realized Investment Gains (Losses) ($80k) $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($81.7m) ($34.4m) ($54.4m) $68.1m ($84.6m) ($140.8m) ($172.7m) ($206.5m) ($612.5m) $51.5m
Net Income (Loss) Attributable to Parent ($81.7m) $68.0m ($84.6m) ($140.8m) ($176.1m) ($205.3m) ($599.5m) ($1.6m)
Net Income (Loss) Attributable to Noncontrolling Interest $0 $0 ($431k) ($4.0m) ($10.2m) $31.7m
Earnings Per Share, Basic ($0.47) ($0.65) $0.72 ($0.84) ($1.36) ($1.67) ($1.92) ($5.00) ($0.01)
Earnings Per Share, Diluted ($1.34) ($0.47) ($0.65) $0.69 ($0.84) ($1.36) ($1.67) ($1.92) ($5.00) ($0.01)
Weighted Average Number of Shares Outstanding, Basic 93.9m 100.7m 103.7m 105.4m 106.8m 119.8m 133.8m
Weighted Average Number of Shares Outstanding, Diluted 98.6m 100.7m 103.7m 105.4m 106.8m 119.8m 133.8m
Research and Development Expense $607.2m
General and Administrative Expense $9.9m $6.8m $19.1m $26.6m $52.3m $81.0m $124.4m $92.5m $98.8m $123.9m
Other Nonoperating Income (Expense) $57k $1.3m $7k ($583k) $2.1m $765k $1.5m ($1.7m) $5.3m
Interest Expense (non-operating) $32.4m $89.4m
Current Income Tax Expense (Benefit) $2k $2k $2k $174k $2k $2k $3.8m $2.8m ($2.8m) $21.4m
Interest Expense $0 $0 $18.3m $32.4m $89.4m
Labor and Related Expense $19.5m $17.3m
Income Tax Expense (Benefit) $2k $2k $2k $174k $2k $2k $3.8m $2.8m ($2.8m) $21.4m
Interest Income (Expense), Nonoperating, Net $266k $415k $1.0m $7.0m $9.2m $6.1m $5.0m